Radiation therapy takes toll on prostate cancer patients' finances
December 1, 2020 -- Prostate cancer was associated with a significant financial burden for 15% of men with early-stage prostate cancer -- with external-beam radiation therapy causing the biggest hit to the wallet -- in a study published November 30 in the Journal of Urology.
Varian to start 1st human trial of Flash rad therapy
November 19, 2020 -- Radiation therapy firm Varian Medical Systems and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the start of the first human clinical trial of Flash therapy.
RefleXion inks contract with proton therapy provider
November 16, 2020 -- Radiation therapy developer RefleXion Medical has announced a contract to provide its biology-guided radiotherapy technology to Integrated Proton Solutions, a turnkey proton therapy provider in the U.S.
Varian teams up with oncology data curator
November 10, 2020 -- Radiation oncology vendor Varian has completed a $10 million investment and signed a collaboration agreement with oncology clinical data curator Cota.
Coding and documentation for Y-90 radioembolization
November 9, 2020 -- The treatment of liver tumors using yttrium-90 (Y-90) radioembolization brings unusual challenges for interventional radiologists. Erin Stephens of Healthcare Administrative Partners describes how to overcome them.  Discuss
ViewRay's revenue plummets in Q3
November 6, 2020 -- Image-guided radiation therapy vendor ViewRay announced its revenue for the third quarter was nearly half of what it was a year ago.
Isotopia partners with Y-mAbs on radioisotope
November 6, 2020 -- Isotopia Molecular Imaging is collaborating with biopharmaceutical company Y-mAbs Therapeutics for the supply of the medical radioisotope no-carrier-added lutetium-177.
Shine makes 1st commercial sales of Lu-177
November 4, 2020 -- Medical isotope firm Shine Medical Technologies made its first commercial sales of its lutetium-177 (Lu-177) therapeutic isotope to multiple customers.
Prelude highlights ASTRO data on breast cancer risk test
October 30, 2020 -- Molecular diagnostics developer Prelude presented data at the American Society for Radiation Oncology (ASTRO) 2020 annual meeting showing that its DCISionRT test can reclassify breast cancer risk in women.
Accuray's fiscal Q1 revenue declines
October 30, 2020 -- Radiation oncology firm Accuray has released financial results for its first quarter of fiscal 2021 that show a drop in revenue from last year.
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more